Curtis A. Johnson

发表

Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients1

Y. Becker, A. Djamali, B. Becker, 2003, Transplantation.

Staphylococcus Aureus Peritoneal Catheter-Related Infections: A Cause of Catheter Loss and Peritonitis

S. Zimmerman, Curtis A. Johnson, M. O'Brien, 1988 .

Trends in anemia management among US hemodialysis patients.

L. Szczech, W. Owen, D. Reddan, 2002, Journal of the American Society of Nephrology : JASN.

Acute and Chronic Renal Failure

Curtis A. Johnson, 1992 .

Dialysis Clinic: Safety of Propoxyphene in Dialysis Patients

G. Bailie, Curtis A. Johnson, 2002 .

Parenteral iron products for anemia in end-stage renal disease: Comparative considerations

G. Bailie, N. Mason, Curtis A. Johnson, 2000 .

Analysis of renal bone disease treatment in dialysis patients.

G. Bailie, Jan Deane, Curtis A. Johnson, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Clinical Pharmacokinetics During Continuous Ambulatory

E. Abdel-Rahman, S. Zimmerman, Curtis A. Johnson, 1996, Clinical pharmacokinetics.

Comparative Review of the Pharmacokinetics of Vitamin D Analogues

G. Bailie, Curtis A. Johnson, 2002, Seminars in dialysis.

The Therapeutic Use of Azathioprine in Renal Transplantation

D. Canafax, G. Chan, Curtis A. Johnson, 1987, Pharmacotherapy.

Review article: Renal support in critical illness

R. Bellomo, N. Pannu, S. Bagshaw, 2010, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

The Pharmacokinetics of Antibiotics Used to Treat Peritoneal Dialysis-Associated Peritonitis

M. Rogge, S. Zimmerman, Curtis A. Johnson, 1984 .

Ampicillin and Sulbactam Pharmacokinetics and Pharmacodynamics in Continuous Ambulatory Peritoneal Dialysis (CAPD)

W. Craig, S. Zimmerman, J. Leggett, 1990, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Multiple Dose IP Vancomycin Kinetics during CAPD

P. Welling, M. Rogge, S. Zimmerman, 1986 .

Impact of nurse case manager-pharmacist collaboration on adverse-drug-event reporting.

P. Lata, Curtis A. Johnson, Marianne Mainhardt, 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Pharmacokinetics of Quinupristin-Dalfopristin in Continuous Ambulatory Peritoneal Dialysis Patients

S. Zimmerman, W. Bridson, P. Chevalier, 1999, Antimicrobial Agents and Chemotherapy.

Single‐dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease

J. Haynes, S. Zimmerman, C. Halstenson, 1992, Clinical pharmacology and therapeutics.

Regional variability in anaemia management and haemoglobin in the US.

M. Rocco, L. Szczech, W. Owen, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project.

B. Fivush, B. Warady, A. Brem, 2003, Kidney international.

Pharmacokinetics of Tazobactam M1 Metabolite After Administration of Piperacillin/Tazobactam in Subjects with Renal Impairment

W. Keane, C. Lathia, K. Tantillo, 1994, Journal of clinical pharmacology.

Serum Advanced Glycosylation End-Products in Patients on Hemodialysis and CAPD

C. Johnson, A. Ateshkadi, S. Zimmerman, 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Comparison of Intraperitoneal and Subcutaneous Epoetin Alfa in Peritoneal Dialysis Patients a

M. Kosorok, C. Johnson, S. Zimmerman, 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Use of Androgens in Patients with Renal Failure

C. Johnson, Curtis A. Johnson, 2000, Seminars in dialysis.

Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.

C. Decker, Curtis A. Johnson, Patrick Cory, 2009, Journal of the American Pharmacists Association : JAPhA.

Rifampin Use in Peritoneal Dialysis

C. Johnson, S. Zimmerman, Curtis A. Johnson, 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Review article: Acute kidney injury in critical illness

R. Bellomo, N. Pannu, S. Bagshaw, 2010, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Diuretic therapies in low renin and normal renin essential hypertension

J. Kotchen, T. Kotchen, C. Brooks, 1977, Clinical pharmacology and therapeutics.

CHAPTER 59 – Treatment of Anemia in Peritoneal Dialysis Patients

S. Zimmerman, M. Wakeen, Curtis A. Johnson, 2008 .

Opportunities and responsibilities for pharmacists on short-term medical mission teams.

M. Schroeder, Curtis A. Johnson, Nora Stieglitz, 2009, Journal of the American Pharmacists Association : JAPhA.

Review article: Renal support in critical illness Article de synthese: La suppleance renale en cas de maladie grave

R. Bellomo, N. Pannu, S. Bagshaw, 2010 .

Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 End-Stage Renal Disease Core Indicators Project.

M. Rocco, W. Owen, W. McClellan, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.

M. Rocco, W. Owen, C. Johnson, 2000, Kidney international.

Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.

W. Craig, E. Roecker, C. Johnson, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.